Infrared spectroscopy can be harnessed to detect molecular traces that tissue tumors leave in our bloodstream, without invasive tissue biopsies. This is the result of a study carried out by the Broadband Infrared Diagnostics (BIRD) research team in the attoworld group of the Chair of Laser Physics at Ludwig-Maximilians-Universität München (LMU) In October 2021. The scientists presented the approach, state of research and individual merits of this study of diagnostic detection of cancer in the science magazine eLife. In light of establishing a new minimally-invasive blood-based detection of cancer, the realm and possibility to detect cancer earlier and thus improve on available therapeutic procedures is getting closer.
Accompanying this publication, Dr. Kosmas Kepesidis, Senior Scientist and Data Analyst of the Broadband Infrared Diagnostics (BIRD) team, reports in this video on the research results to date, milestones achieved and continues to provide an outlook on current and future developments. The newly and specially designed, extremely sensitive analysis apparatuses from the field of ultrashort-pulse laser technology are already able to achieve far more precise results, which, through the evaluation of the latest machine-learning algorithms procedures, provide for a much more reliable and comprehensive data set.